Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy:Two case reports and literature review  

在线阅读下载全文

作  者:Tomas Koller Petra Vrbova Iveta Meciarova Pavol Molcan Michal Smitka Svetlana Adamcova Selcanova Lubomir Skladany 

机构地区:[1]Gastroenterology and Hepatology Subdiv.5th Department of Internal Medicine,Comenius University Faculty of Medicine,University Hospital Bratislava,82606,Slovakia [2]Department of Pathology,Alpha medical Patológia s.r.o.,Bratislava 82606,Slovakia [3]HEGITO(Division of Hepatology,Gastroenterology and Liver Transplantation),Department of Internal Medicine II of Slovak Medical University,F.D.Roosevelt University Hospital,Banska Bystrica 97517,Slovakia [4]Department of Pathology,FD Roosevelt Hospital,Banska Bystrica 97517,Slovakia

出  处:《World Journal of Clinical Cases》2021年第16期4062-4071,共10页世界临床病例杂志

摘  要:BACKGROUND Muscle growth promoters are being developed for the treatment of diseaseinduced loss of muscle mass.Ligandrol and ostarine are selective androgen receptor modulators(SARMs)with a non-steroidal structure and a presumably more favorable side effect profile.In recent years,these substances with or without“post-cycle therapy”(PCT)are often misused by amateur athletes aiming to promote muscle growth.At the same time,reports on their toxic effects on organ systems are emerging.CASE SUMMARY We report two cases of liver injury in young men who used ligandrol and/or ostarine for a few weeks followed by the use of substances for PCT.Acute liver injury occurred in both cases after stopping SARMs while on PCT.The clinical picture was dominated by jaundice and fatigue.The biochemical pattern showed a mixed type of injury with normal alkaline phosphatase and high concentrations of bilirubin and serum bile acids. Histological evidence showed predominantlycholestatic injury with canalicular bile plugs, ductopenia, and mild hepatocellulardamage without significant fibrosis. The patients recovered from the conditionafter 3 mo. The off target effects of SARMs were likely idiosyncratic, but ourreport highlights the yet unrecognized effects of other toxic substances used forPCT, supra-therapeutic doses, and the complete absence of monitoring foradverse effects.CONCLUSIONAmong muscle-building amateur athletes, SARMs (ligandrol or ostarine) and/orsubstances in PCT may cause cholestatic liver injury with prolonged recovery.

关 键 词:Drug induced liver injury Ligandrol Ostarine CHOLESTASIS Anabolic substances Ductopenia Case report 

分 类 号:R575[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象